William Quinn | SVP, Finance & Corporate Development and CFO |
Dayton Misfeldt | Interim CEO & Director |
Judith Fox | Chief Scientific Officer |
Marc Frahm | Cowen and Company |
Hartaj Singh | Oppenheimer |
Good day, ladies and gentlemen, and welcome to the Sunesis Pharmaceuticals Third Quarter 2018 Earnings Conference Call. [Operator Instructions].
As a reminder, this call is being recorded. I would now like to introduce your host, Willie Quinn, Chief Financial Officer and Senior Vice President, Corporate Development. Please go ahead.